Presentation is loading. Please wait.

Presentation is loading. Please wait.

Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?  Ruzena.

Published byArleen Atkins Modified over 5 years ago

Similar presentations

Presentation on theme: "Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?  Ruzena."— Presentation transcript:

1 Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?  Ruzena Tkacova, MD, PhD, Darlene L.Y. Dai, MSc, Judith M. Vonk, PhD, Janice M. Leung, MD, Pieter S. Hiemstra, PhD, Maarten van den Berge, MD, PhD, Lisette Kunz, MD, Zsuzsanna Hollander, PhD, Donald Tashkin, MD, Robert Wise, MD, John Connett, PhD, Raymond Ng, PhD, Bruce McManus, MD, PhD, S.F. Paul Man, MD, Dirkje S. Postma, MD, PhD, Don D. Sin, MD  Journal of Allergy and Clinical Immunology  Volume 138, Issue 6, Pages e10 (December 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Decline in FEV1 (A) and absolute FEV1 (B) in patients with COPD with AHR and without AHR (black, PC20 cutoff of 4 mg/mL; red, PC20 cutoff of 15 mg/mL) in the LHS. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Estimates of cumulative incidence of respiratory mortality (A), cardiovascular disease (CVD) mortality (B), and total mortality (C) for patients with COPD with AHR and without AHR (non-AHR) (black, PC20 cutoff of 4 mg/mL; red, PC20 cutoff of 15 mg/mL). For each plot, x-axis is follow-up in years from the date of blood draw to the end of the passive follow-up of the LHS and y-axis is the probability of mortality for a given time. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 AIC of respiratory death, indicating the best goodness of fit, of different thresholds of PC20. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E1 Decline in FEV1 (boxplots) in patients with COPD with AHR and without AHR (PC20 cutoff of 4 mg/mL) in the LHS. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E2 AIC for FEV1 decline, indicating the best goodness of fit, of different thresholds of PC20—linear model (A), and treating time as a discrete variable (B). Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E3 Receiver operating characteristic curves of airway responsiveness (PC20), BDR, and smoking status for FEV1 decline of more than 120 mL over 3 years. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?  Ruzena."

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,

Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2.

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,

Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma  Anand C. Patel, MD, Mark L. Van Natta, MHS, James.

Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma  Anand C. Patel, MD, Mark L. Van Natta, MHS, James.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
No evidence of large genetic effects on steroid response in asthma patients  Michael Mosteller, PhD, Louise Hosking, BSc, Kay Murphy, PhD, Judong Shen,

No evidence of large genetic effects on steroid response in asthma patients  Michael Mosteller, PhD, Louise Hosking, BSc, Kay Murphy, PhD, Judong Shen,
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study

Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease  Michael A. Ghebre, MSc, Mona.

Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease  Michael A. Ghebre, MSc, Mona.

Similar presentations

Ads by Google